Fund HoldingsAtlas Venture Life Science Advisors, LLC

Total Portfolio Value
$1.08B
Total Bought
$0
Total Sold
$92.52M
Net Transaction
-$92.52M
Filing Period:
Securities
SharesValue ($K)
Q2 2024
Q3 2024
Change
Q2 2024
Q3 2024
Weight (%)
Change
Kymera Therapeutics, Inc.(KYMR)5,350,4224,896,462-453,960159,710231,75021.48%+72,039
Q32 Bio, Inc.2,092,1062,092,106037,55393,3508.65%+55,796
Disc Medicine, Inc.(IRON)2,509,4562,509,4560113,101123,31511.43%+10,213
Third Harmonic Bio, Inc.10,907,85910,907,8590141,802147,80113.70%+5,999
Tectonic Therapeutics, Inc.378,447378,44706,23311,4671.06%+5,234
Dyne Therapeutics, Inc.(DYN)8,020,1368,020,1360283,031288,08326.71%+5,053
Day One Biopharmaceuticals, Inc.
COM
6,430,2576,430,257088,60989,5738.30%+965
Aerovate Therapeutics, Inc.1,799,2321,799,23202,9873,7600.35%+774
Ikena Oncology, Inc.5,018,1785,018,17808,2808,6810.80%+401
Spero Therapeutics, Inc.535,336402,885-132,4516965400.05%-156
Korro Bio, Inc.1,137,1491,137,149038,51538,0043.52%-512
Dianthus Therapeutics, Inc.(DNTH)136,97976,979-60,0003,5452,1080.20%-1,437
Generation Bio, Co.8,279,4848,279,484023,34820,4501.90%-2,898
Vigil Neuroscience, Inc.5,836,8745,836,874023,34719,8451.84%-3,502
Replimune Group, Inc.(REPL)2,098,3000-2,098,30018,8850-18,885
Page 1 of 1